Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Osteoarthritis

Bisphosphonates and OA — is there a bone and joint connection?

Bisphosphonates have been proposed as a potential disease-modifying treatment for osteoarthritis (OA); however, it is as yet unclear if this treatment is effective. Evidence from a new meta-analysis raises the question of whether bisphosphonates can reduce damage in OA.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Key elements of osteoarthritis pathology.

References

  1. Vaysbrot, E. E. et al. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage https://doi.org/10.1016/j.joca.2017.11.013 (2017).

    Article  CAS  Google Scholar 

  2. Spector, T. D. et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISH randomized, controlled trial. Arthritis Res. Ther. 7, R625–R633 (2004).

    Article  Google Scholar 

  3. Bingham, C. O. et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee. Arthritis Rheum. 54, 3494–3507 (2006).

    Article  CAS  Google Scholar 

  4. Hunter, D. J. et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 54, 1529–1535 (2006).

    Article  Google Scholar 

  5. Laslett, L. L. et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomized controlled trial. Ann. Rheum. Dis. 71, 1322–1328 (2012).

    Article  CAS  Google Scholar 

  6. Vareena, M. et al. Intravenous neridronate in the treatment of acute painful knee osteoarthritis; a randomized controlled study. Rheumatology (Oxford) 53, 1826–1832 (2015).

    Article  Google Scholar 

  7. Rossini, M. et al. Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial. Rheumatol. Int. 25, 255–263 (2015).

    Article  Google Scholar 

  8. Chen, Y. et al. Subchondral trabecular rod loss and plate thickening in the development of osteoarthritis. J. Bone Miner. Res. https://doi.org/10.1002/jbmr.3313 (2017).

    Article  Google Scholar 

Download references

Acknowledgements

The work of N.E.L. is supported in part by NIH grant P50 AR063043 and the endowment for geriatrics and rheumatology at UC Davis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nancy E. Lane.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lane, N. Bisphosphonates and OA — is there a bone and joint connection?. Nat Rev Rheumatol 14, 185–186 (2018). https://doi.org/10.1038/nrrheum.2018.18

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2018.18

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing